EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections



T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections



New England Journal of Medicine 318(12): 733-741



Fatal T-cell lymphomas developed in three patients with a chronic illness manifested by fever, pneumonia, dysgammaglobulinemia, hematologic abnormalities, and extraordinarily high titers of antibody to the Epstein-Barr virus (EBV) capsid antigen (greater than 10,000) and early antigen (greater than 640) but low titers to the EBV nuclear antigen (less than or equal to 40). To understand the pathogenesis of these tumors better, we determined the immunophenotype of the tumor cells and analyzed tumor-cell DNA for EBV genomes and for lymphoid-cell gene rearrangements. More than 80 percent of the cells in tumors had an activated helper T-cell phenotype (T4, T11, la positive). The EBV genome was found by in situ hybridization in tumor tissue from each patient. Southern blot assay of DNA digests from one patient showed the same pattern as that of the EBV-infected marmoset line, B95-8. DNA digests from two patients showed a monoclonal proliferation of T cells determined on the basis of uniform T-cell-receptor gene rearrangements and a single band for the joined termini of the EBV genome. We conclude that EBV may infect T cells and contribute to lymphomas in selected patients with severe EBV infections.

(PDF emailed within 0-6 h: $19.90)

Accession: 041529059

Download citation: RISBibTeXText

PMID: 2831453

DOI: 10.1056/NEJM198803243181203



Related references

Molecular size variation of epstein barr virus induced nuclear antigen is determined by the epstein barr viral genome studies on sublines of epstein barr virus negative lymphomas converted with different epstein barr virus substrains and on somatic hybrids. Intervirology 22(2): 85-96, 1984

Relationship between the amounts of epstein barr virus dna and epstein barr virus nuclear antigen per cell clonability and tumorigenicity in 2 epstein barr virus negative lymphoma lines and their epstein barr virus converted sublines. International Journal of Cancer 31(2): 163-170, 1983

Specific allergen-induced Epstein-Barr nuclear antigen-positive B cells from patients with chronic-active Epstein-Barr virus infections. Journal of Allergy and Clinical Immunology 78(2): 315-320, 1986

A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas. American Journal of Pathology 140(6): 1315-1325, 1992

Correlation between allergy and persistent Epstein-Barr virus infections in chronic-active Epstein-Barr virus-infected patients. Journal of Allergy and Clinical Immunology 78(2): 308-314, 1986

Production by epstein barr virus infection of an epstein barr nuclear antigen positive subline from an epstein barr nuclear antigen negative human lymphoma cell line without detectable epstein barr virus dna. International Journal of Cancer 16(1): 125-133, 1975

Establishment of epstein barr virus nuclear antigen expressing cell lines by infection of epstein barr virus genome negative human lymphoma cells with different epstein barr virus strains. International Journal Of Cancer: 161-166, 1976

Infection of mouse lymphocytes by epstein barr virus 2 stimulation of cellular dna synthesis by epstein barr virus in the absence of epstein barr virus determined nuclear antigen induction and cell transformation. 1984

Epstein barr virus lymphoid cell interactions 2. the influence of epstein barr virus replication cycle on natural killing and antibody dependent cellular cyto toxicity against epstein barr virus infected cells. Clinical and Experimental Immunology 48(3): 589-601, 1982

An epstein barr virus genome negative cell line established from an american burkitts lymphoma receptor characteristics epstein barr virus infectibility and permanent conversion into epstein barr virus positive sublines by in vitro infection. Intervirology 5(6): 319-334, 1975

Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma. Leukemia & Lymphoma 56(4): 1072-1078, 2016

An epstein barr virus nuclear antigen negative epstein barr virus genome positive human lymphoblast cell line in which superinfecting epstein barr virus dna is not maintained. Virology 137(1): 113-126, 1984

A distinct subtype of Epstein Barr virus positive T/NK-cell lymphoproliferative disorder: Adult patients with chronic active Epstein Barr virus infection-like features. Haematologica: -, 2017

Epstein barr virus antibodies immuno globulin g and immuno m anti viral capsid antigen immuno globulin g anti early antigen and immuno globulin anti nuclear antigen obtained with an original micro titer technique serological criteria of primary and recurrent epstein barr virus infections and follow up of infectious mononucleosis sero epidemiology of epstein barr virus in belgium based on 5178 sera from patients. Acta Clinica Belgica 37(5): 281-298, 1982

Viral DNA contamination is responsible for Epstein-Barr virus detection in cytotoxic T lymphocytes stimulated in vitro with Epstein-Barr virus B-lymphoblastoid cell line. Cancer Immunology, ImmunoTherapy 59(12): 1867-1875, 2010